Business Expenses. During the Term, the Company shall reimburse Executive for all reasonable travel and other business expenses incurred by Executive in the performance of Executive’s duties to the Company in accordance with the Company’s expense reimbursement Policy.
Seres Therapeutics, Inc. (MCRB) (CIK 0001609809)
Source: SEC EDGAR database • Date: August 6, 2019 • SIC: 2834 • CIK: 2834
Merus N.V. (MRUS) (CIK 0001651311)
Source: SEC EDGAR database • Date: March 16, 2020 • SIC: 2834 • CIK: 2834
Seres Therapeutics, Inc. (MCRB) (CIK 0001609809)
Source: SEC EDGAR database • Date: July 28, 2020 • SIC: 2834 • CIK: 2834
Lyra Therapeutics, Inc. (LYRA) (CIK 0001327273)
Source: SEC EDGAR database • Date: March 9, 2022 • SIC: 3841 • CIK: 3841
Seres Therapeutics, Inc. (MCRB) (CIK 0001609809)
Source: SEC EDGAR database • Date: March 2, 2021 • SIC: 2834 • CIK: 2834
Homology Medicines, Inc. (FIXX) (CIK 0001661998)
Source: SEC EDGAR database • Date: March 12, 2019 • SIC: 2834 • CIK: 2834
LogMeIn, Inc. (LOGM) (CIK 0001420302)
Source: SEC EDGAR database • Date: February 14, 2020 • SIC: 7372 • CIK: 7372
Seres Therapeutics, Inc. (MCRB) (CIK 0001609809)
Source: SEC EDGAR database • Date: November 5, 2019 • SIC: 2834 • CIK: 2834
Seres Therapeutics, Inc. (MCRB) (CIK 0001609809)
Source: SEC EDGAR database • Date: November 9, 2020 • SIC: 2834 • CIK: 2834